THE ROLE OF GROWTH-HORMONE INSULIN-LIKE GROWTH-FACTORS IN ADIPOCYTE DIFFERENTIATION

被引:131
作者
WABITSCH, M [1 ]
HAUNER, H [1 ]
HEINZE, E [1 ]
TELLER, WM [1 ]
机构
[1] UNIV DUSSELDORF,DIABET RES INST,W-4000 DUSSELDORF,GERMANY
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1995年 / 44卷 / 10期
关键词
D O I
10.1016/0026-0495(95)90220-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Growth of the adipose tissue results from both the enlargement of mature adipocytes and the formation of new adipocytes from adipocyte precursor cells. The differentiation process of adipocyte precursor cells is controlled by a variety of hormones. Clinical observations indicate that growth hormone (GH) and insulin-like growth factor I (IGF-I) are able to influence the growth of the adipose organ. Recent in vitro studies using cultures of clonal and primary adipocyte precursor cells have elucidated the role of GH and IGF-I in adipocyte differentiation. From these studies it can be concluded that GH is able to enlarge the pool of adipocyte precursor cells capable of differentiating into mature adipocytes, which occurs under the control of other adipogenic hormones. However, due to its metabolic action, GH is also able to reduce the volume of mature adipocytes and thus the net result of its biological action is aimed at reducing body fat. IGF-I stimulates the differentiation process by inducing critical cell divisions of adipocyte precursor cells necessary for their differentiation. IGF-I, which is known to be regulated by GH and several nutritional factors, may exert its effects in the adipose tissue in an autocrine/paracrine and endocrine way. This review summarizes the results of recent studies investigating the role of GH and IGF-I in adipocyte differentiation. Copyright (C) 1995 by W.B. Saunders Company.
引用
收藏
页码:45 / 49
页数:5
相关论文
共 58 条
[1]   CELLULAR AND MOLECULAR ASPECTS OF ADIPOSE-TISSUE DEVELOPMENT [J].
AILHAUD, G ;
GRIMALDI, P ;
NEGREL, R .
ANNUAL REVIEW OF NUTRITION, 1992, 12 :207-233
[2]   SUBCUTANEOUS ADIPOSE-TISSUE AND LIPIDS IN BLOOD IN GROWTH-HORMONE DEFICIENCY BEFORE AND AFTER TREATMENT WITH HUMAN GROWTH-HORMONE [J].
BONNET, F ;
VANDERSC.M ;
EECKELS, R ;
MALVAUX, P .
PEDIATRIC RESEARCH, 1974, 8 (09) :800-805
[3]  
BROOK CGD, 1972, LANCET, V2, P624
[4]   REDUCTION OF PLASMA-IMMUNOREACTIVE SOMATOMEDIN-C DURING FASTING IN HUMANS [J].
CLEMMONS, DR ;
KLIBANSKI, A ;
UNDERWOOD, LE ;
MCARTHUR, JW ;
RIDGWAY, EC ;
BEITINS, IZ ;
VANWYK, JJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (06) :1247-1250
[5]   GROWTH-HORMONE AND ADIPOSE DIFFERENTIATION - GROWTH HORMONE-INDUCED ANTIMITOGENIC STATE IN 3T3-F442A PREADIPOSE CELLS [J].
CORIN, RE ;
GULLER, S ;
WU, KY ;
SONENBERG, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (19) :7507-7511
[6]   EFFECT OF GROWTH-HORMONE ON CARBOHYDRATE AND LIPID-METABOLISM [J].
DAVIDSON, MB .
ENDOCRINE REVIEWS, 1987, 8 (02) :115-131
[7]   DEVELOPMENT OF A CHEMICALLY DEFINED SERUM-FREE MEDIUM FOR DIFFERENTIATION OF RAT ADIPOSE PRECURSOR CELLS [J].
DESLEX, S ;
NEGREL, R ;
AILHAUD, G .
EXPERIMENTAL CELL RESEARCH, 1987, 168 (01) :15-30
[8]  
DOGLIO A, 1986, BIOCHEM J, V238, P123, DOI 10.1042/bj2380123
[9]   GROWTH-HORMONE STIMULATES C-FOS GENE-EXPRESSION BY MEANS OF PROTEIN KINASE-C WITHOUT INCREASING INOSITOL LIPID TURNOVER [J].
DOGLIO, A ;
DANI, C ;
GRIMALDI, P ;
AILHAUD, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (04) :1148-1152
[10]  
DOGLIO A, 1987, EMBO J, V13, P4011